Jeffrey J. Raizer
Northwestern University(US)Amyotrophic Lateral Sclerosis Therapy Development Institute(US)Northwestern University(PH)Takeda (United States)(US)Northwestern Medicine(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Meningioma and schwannoma management, Chromatin Remodeling and Cancer, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial(2017)1,084 cited
- → Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma(2019)932 cited
- → NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality(2012)831 cited
- → Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome(2013)481 cited
- → Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme(2008)471 cited
- → Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08